Y Gao1, C G Zhu1, N Q Wu1, Y L Guo1, G Liu1, Q Dong1, J J Li1. 1. Department of Dyslipidemia and Cardiovascular Disease, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100037, China.
Abstract
OBJECTIVE: To evaluate the clinical correlation between the CardioChek PA analyzer (CCPA) and a clinical laboratory reference method to use for screening program purposes. METHODS: Fasting blood samples were collected on 325 patients (age: 23-86 years). One venous sample was collected using a serum tube for the evaluation on a Beckman reference analyzer. A second venous sample was collected in a lithium heparin tube and was evaluated on the CCPA analyzer. Linear regression analyses and Bland-Altman method were performed for each measured analyte: total cholesterol (TC), high density lipoprotein-cholesterol (HDL-C), triglycerides (TG) and low density lipoprotein-cholesterol (LDL-C). RESULTS: Our results demonstrated a good clinical agreement for TC, HDL-C, TG and LDL-C(97.0%, 92.9%, 92.4% and 83.7%)in comparison with the CCPA to the reference analyzer. The correlation coefficients were 0.875, 0.813, 0.910, 0.864, respectively. P values all < 0.001. There was no significant difference in the detection rate of hyperlipidemia in TC, HDL-C and LDL-C. CONCLUSION: We have identified the pre-analytic phase as an important step to guarantee the quality of results and indicated that the CCPA is a reliable lipid point-of-care testing system that can be used for the application of clinical screening anywhere.
OBJECTIVE: To evaluate the clinical correlation between the CardioChek PA analyzer (CCPA) and a clinical laboratory reference method to use for screening program purposes. METHODS: Fasting blood samples were collected on 325 patients (age: 23-86 years). One venous sample was collected using a serum tube for the evaluation on a Beckman reference analyzer. A second venous sample was collected in a lithium heparin tube and was evaluated on the CCPA analyzer. Linear regression analyses and Bland-Altman method were performed for each measured analyte: total cholesterol (TC), high density lipoprotein-cholesterol (HDL-C), triglycerides (TG) and low density lipoprotein-cholesterol (LDL-C). RESULTS: Our results demonstrated a good clinical agreement for TC, HDL-C, TG and LDL-C(97.0%, 92.9%, 92.4% and 83.7%)in comparison with the CCPA to the reference analyzer. The correlation coefficients were 0.875, 0.813, 0.910, 0.864, respectively. P values all < 0.001. There was no significant difference in the detection rate of hyperlipidemia in TC, HDL-C and LDL-C. CONCLUSION: We have identified the pre-analytic phase as an important step to guarantee the quality of results and indicated that the CCPA is a reliable lipid point-of-care testing system that can be used for the application of clinical screening anywhere.
Authors: Victor M Oguoma; Ezekiel U Nwose; Ifeoma I Ulasi; Adeseye A Akintunde; Ekene E Chukwukelu; Phillip T Bwititi; Ross S Richards; Timothy C Skinner Journal: BMC Public Health Date: 2017-01-06 Impact factor: 3.295
Authors: Danladi I Musa; Abel L Toriola; Daniel T Goon; Sunday U Jonathan Journal: Int J Environ Res Public Health Date: 2020-08-13 Impact factor: 3.390
Authors: M A McNarry; L Lester; E A Ellins; J P Halcox; G Davies; C O N Winn; K A Mackintosh Journal: Eur J Appl Physiol Date: 2021-03-29 Impact factor: 3.078